SCHEMBL260830

SCHEMBL260830

CCC(C(=O)O)c1c(-c2ccccc2C)[nH]c2cccc([N+](=O)[O-])c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
FBP1 P09467 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
CNR1 P21554 3/20 0.37
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL260831 1.00 MGAM (0.42) MGAMGAASIMGAM2FBP1
SCHEMBL260240 0.81 FBP1 (0.41) FBP1L3MBTL1TDP1TSHRCYP1A2
SCHEMBL260657 0.80 CYP1A2 (0.40) FBP1L3MBTL1TDP1TSHRCYP1A2
SCHEMBL2884271 0.79 GAA (0.46) MGAMGAASIMGAM2FBP1
SCHEMBL2884268 0.79 GAA (0.46) MGAMGAASIMGAM2FBP1
SCHEMBL260294 0.71 CYP1A2 (0.45) MGAMGAASIMGAM2FBP1
SCHEMBL6009063 0.70 TSHR (0.55) MGAMGAASIMGAM2L3MBTL1
SCHEMBL475205 0.67 CYP1A2 (0.72) L3MBTL1TDP1TSHRCYP1A2HSD17B10
SCHEMBL475201 0.67 CYP1A2 (0.72) L3MBTL1TDP1TSHRCYP1A2HSD17B10
SCHEMBL6007713 0.66 TDP1 (0.52) MGAMGAASIMGAM2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163752-B2 Tricyclic anilide heterocyclic CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-04-24 US disclosed
US-8133891-B2 Tricyclic anilide spirolactam CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-03-13 US disclosed